file: NCSR > section: Pharmacoepidemiology > variable: MEDICATION6 > language: English
| <-- previous variable | next variable --> |
PH4
IF NEC, ASK R TO CONSULT MEDICATION BOTTLES FOR MED NAMES.
(What were their names?)
PROBE UNTIL NO MORE MENTIONS: Any others?
PRESS ENTER ON A BLANK MEDICATION FIELD TO LEAVE THE ROSTER
Additional Documentation
| Value | Label | Frequency | Valid Percent | Total Percent |
|---|---|---|---|---|
| 7 | AMITRIPTYLINE | 1 | 02.50% | 00.01% |
| 29 | CELEXA | 1 | 02.50% | 00.01% |
| 33 | CITALOPRAM | 1 | 02.50% | 00.01% |
| 42 | COGENTIN | 1 | 02.50% | 00.01% |
| 47 | DEPAKOTE | 1 | 02.50% | 00.01% |
| 51 | DESYREL | 1 | 02.50% | 00.01% |
| 56 | DIAZEPAM | 1 | 02.50% | 00.01% |
| 65 | EFFEXOR | 2 | 05.00% | 00.02% |
| 66 | ELAVIL | 2 | 05.00% | 00.02% |
| 69 | ESKALITH | 1 | 02.50% | 00.01% |
| 74 | FLUOXETINE | 1 | 02.50% | 00.01% |
| 83 | HALDOL | 1 | 02.50% | 00.01% |
| 105 | LORAZEPAM | 1 | 02.50% | 00.01% |
| 114 | MEPROBAMATE | 1 | 02.50% | 00.01% |
| 124 | MOCLOBEMIDE | 1 | 02.50% | 00.01% |
| 133 | NORTRIPTYLINE | 1 | 02.50% | 00.01% |
| 139 | PAMELOR | 1 | 02.50% | 00.01% |
| 141 | PAROXETINE | 1 | 02.50% | 00.01% |
| 142 | PAXIL | 2 | 05.00% | 00.02% |
| 148 | PHENERGAN | 1 | 02.50% | 00.01% |
| 163 | REMERON | 1 | 02.50% | 00.01% |
| 165 | RESTORIL | 1 | 02.50% | 00.01% |
| 175 | SERZONE | 1 | 02.50% | 00.01% |
| 179 | SONATA | 1 | 02.50% | 00.01% |
| 193 | TRAZODONE | 2 | 05.00% | 00.02% |
| 201 | VALIUM | 1 | 02.50% | 00.01% |
| 208 | VIVACTIL | 1 | 02.50% | 00.01% |
| 209 | WELLBUTRIN | 2 | 05.00% | 00.02% |
| 210 | XANAX | 3 | 07.50% | 00.03% |
| 212 | ZOLOFT | 2 | 05.00% | 00.02% |
| 215 | ZYPREXA | 1 | 02.50% | 00.01% |
| 997 | OTHER | 1 | 02.50% | 00.01% |
| -8 | DONT KNOW | 1 | - | 00.01% |
| . | Missing | 9241 | - | 99.56% |
Disclaimer: Frequencies displayed above are not weighted.
You can also view this variable in SDA
.
You can choose to scroll through all the questions in this section . Be warned that this can be rather slow.
| <-- previous variable | next variable --> |